baber/WOPTO huggingface dataset:
Patent FI-914406-A0 (FI)
Inventor: WAGNER HARTMUT
IPC: C01G23/053
Filed: 1991-09-19
Abstract: The process of concentrating a dilute sulfuric acid in a three-stage vacuum evaporation plant includes feeding an entry dilute sulfuric acid to a first evaporation stage of a vacuum evaporation plant to form an overhead vapor (6), withdrawing a finally concentrated sulfuric acid from the third evaporation stage (3), using steam or the overhead vapor (6) of the first evaporation stage as a heating fluid in the three-stage vacuum evaporation plant, maintaining the entry dilute sulfuric acid under a pressure of 0.4 to 0.7 bar and at a temperature of 80 DEG  to 120 DEG  C. in the first evaporation stage (1), maintaining the partially concentrated sulfuric acid under a pressure of 0.02 to 0.06 bar and at a temperature of 50 DEG  to 90 DEG  C. in the second evaporation stage (2), maintaining the further concentrated sulfuric acid under a pressure of 0.02 to 0.06 bar and at a temperature of 80 DEG  to 120 DEG  C. in the third evaporation stage (3), and condensing overhead vapors (8,8a) formed in the second and third evaporation stages. Each evaporation stage (1,2,3) includes an evaporation vessel (1b,2b,3b) and a connected recycle line including a shell-tube heat exchanger (1a,2a,3a) and pump. The process also includes continuously feeding about 30 to 95% of the entry dilute sulfuric acid (4) to the first evaporation vessel in the first evaporation stage (1) and continuously feeding the balance of the entry dilute sulfuric acid to the second evaporation vessel in the second evaporation stage (2).
Patent FI-930970-A0 (FI)
Inventor: HEITSCH HOLGER
IPC: C07D233/90
Filed: 1993-03-04
Abstract: Compounds of the formula (I) <IMAGE>  in which     R<1> is, for example, ethyl,   R<2> is, for example, methyl,   n is, for example, zero,   R<3> is, for example, COOH and   R<4> is, for example, SO2NHCONHCH3 are highly active antagonists of angiotensin II receptors.
Patent FI-931643-A0 (FI)
Inventor: BAECKERUD STIG LENNART
IPC: G01N33/20
Filed: 1993-04-13
Abstract: PCT No. PCT/SE91/00685 Sec. 371 Date Apr. 15, 1993 Sec. 102(e) Date Apr. 15, 1993 PCT Filed Oct. 11, 1991 PCT Pub. No. WO92/06809 PCT Pub. Date Apr. 30, 1992.A method relating to the production of cast iron castings with compacted graphite crystals. The method comprises controlling and correcting the composition of the cast iron melt and securing the necessary amount of structure modifying agent. A sample of the melt is taken with a sample vessel provided with two thermocouples, one positioned so as to be in the centre of the sample and the other positioned so as to be in the vicinity of the vessel wall. The vessel wall contains or is coated with a layer of a substance which will lower the concentration of dissolved elementary magnesium in the melt in the vicinity of the vessel wall by at least 0.0030%. The temperature/time values obtained through two temperature responsive means are recorded. The occurrence of a plateau temperature will provide information as to the precipitation of flaky graphite in the vicinity of the vessel wall, therewith enabling corrections to be made to the concentration of the modifying agent and to ensure the formation of compacted graphite crystal during the whole of the pouring time required in the foundry process concerned.
Patent FI-933317-A0 (FI)
Inventor: DANIELSON BO G
IPC: A61M39/00
Filed: 1993-07-23
Abstract: PCT No. PCT/SE91/00899 Sec. 371 Date Aug. 17, 1993 Sec. 102(e) Date Aug. 17, 1993 PCT Filed Dec. 20, 1991 PCT Pub. No. WO92/13590 PCT Pub. Date Aug. 20, 1992.In a fluid conduit connecting device for medical purposes a housing and a connecting member, being connectable to the housing, carry cooperating sealing surfaces. For the purpose of protecting the sealing surfaces of the connecting member these surfaces are covered by protective surfaces of a protective member prior to the connection of the connecting member to the housing. Protective member is arranged to uncover the sealing surfaces when the connection into the housing takes place. The device is suitable particularly for connecting the blood stream of a patient to an external conduit and allows continuous arteriovenous hemofiltration.
Patent FI-934695-A0 (FI)
Inventor: WILLIAMS DAVID MARK
IPC: B26B9/00
Filed: 1993-10-22
Abstract: PCT No. PCT/GB92/00756 Sec. 371 Date Dec. 8, 1993 Sec. 102(e) Date Dec. 8, 1993 PCT Filed Apr. 24, 1992 PCT Pub. No. WO92/19424 PCT Pub. Date Nov. 12, 1992.The invention relates to knife blades and in particular to a method of their production, and has for its object the provision of a knife blade with a cutting edge formed by a surface harder than the material of the body of the blade. This objective is met by a method comprising grinding a first face (2) of a V-shaped cutting edge to one side of the blank (1) to locate the lower edge of the first side face (2) at the approximate mid-point across the thickness of the blank (1), providing on the partly-ground blank (1) a hard surface (3) around the periphery of the blank (1) at least over the height of the first ground face (2) and grinding a second face (4) of the V-shaped cutting edge to the opposite side of the blank (1), to locate the V-shaped cutting edge at the approximate mid-point across the thickness of the blank (1).
Patent FI-935763-A0 (FI)
Inventor: SCHUETT KARL
IPC: G01B7/24
Filed: 1993-12-21
Abstract: The monitoring device for structural elements, in particular for tension members in earth or rock anchors, compression members of piles, tendons for prestressed concrete structures and bridge cables has at least one sensor channel (15), arranged inside or outside a structural member (1) for accommodating at least one sensor (16). The sensor (16) is arranged movably and/or detachably in the sensor channel (15). The presence of corrosion, cracks, excessive loads, overelongations and ageing relaxation is determined by an evaluation device (18) from the at least one sensor signal. <IMAGE>
Patent FI-942240-A0 (FI)
Inventor: QUALLICH GEORGE J
IPC: C07F5/02
Filed: 1994-05-13
Abstract: The anantoselective borane reduction of prochiral ketones to optically pure alcohols is effectively achieved by performing the reduction in the precence of catalytic amounts of the new and valuable oxazaborolidine compounds of formulas (I) and (II). The compounds of formulas (I) and (II) may be isolated and purified prior to use in the reduction reactions or the compounds of formulas (I) and (II) may be generated in situ.
Patent FI-944770-A0 (FI)
Inventor: LABEEUW BERNARD
IPC: A61P1/00
Filed: 1994-10-11
Abstract: The subject of the invention is substituted 1-naphthylpyrazole-3-carboxamides of formula I: <IMAGE>   Application: treatment of neuropsychiatric disorders, in particular those which are associated with dysfunctioning of the dopaminergic systems.
Patent FI-961226-A0 (FI)
Inventor: PETERS GUNTHER
IPC: A24D1/00
Filed: 1996-03-15
Abstract: A ventilated filter cigarette has a multiple filter with a higher global retention provided in different sections with ventilation perforations. The ventilated filter cigarette contains a tobacco mixture of expanded tobacco having a high nicotine content. The tobacco mixture contains as constitutive element expanded tobacco lamina with a nicotine content from 1.0 % to 8 % and/or tobacco foil with a nicotine content from 5 % to 10 %, to which fruit acid is incorporated. The tobacco mixture has a nicotine content from 2.5 % to 5 %. The resistance to draw of the multiple filter is higher at the tow side than at the mouth side, and the degree of ventilation lies in a range from 50 % to 95 % added air. The main smoke flow preferably has an "American blend" taste with an approximately constant taste per puff. The pH value of the smoke lies in a range from 6.0 to 7.5. While giving good sensory results, the cigarettes have condensate and nicotine values respectively of less than 1 mg/cigarette and 0.1 mg/cigarette and in special cases of less than 3 mg/cigarette and less than 0.6 mg/cigarette.
Patent FI-961409-A0 (FI)
Inventor: HOFERICHTER FRANK
IPC: B01F29/62
Filed: 1996-03-28
Abstract: PCT No. PCT/DE94/01094 Sec. 371 Date Feb. 26, 1996 Sec. 102(e) Date Feb. 26, 1996 PCT Filed Sep. 15, 1994 PCT Pub. No. WO95/09074 PCT Pub. Date Apr. 6, 1995A transporter-mixer for bulk-material/liquid mixtures has a cylindrical transport container mounted on a support frame with its longitudinal axis approximately horizontal and a controllable container-drive unit whose direction is reversible as a function of the angle of rotation. Fitted on the transport container periphery is a closable loading hatch which opens into the transport container. Mounted on the transport container's inside wall is a mixing screw and at a rear end of the container is an annular discharge channel with an inwards-facing discharge port. The mean height of the mixing screw is, at the most, 15% of the container diameter and a curved, enclosed guide channel of essentially constant cross-section connects the annular discharge channel and a central discharge port.
Patent FI-962675-A0 (FI)
Inventor: FOURTY GEORGES
IPC: C08J3/22
Filed: 1996-06-28
Abstract: Method of incorporation a talcum powder into a material, in particular a thermoplastic material. The method consists in (a) mixing the talcum powder with water and a polyethylene glycol, a polypropylene glycol or a copolymer of these compounds, (b) pressing the mixture through dies and sectioning it to obtain granules of an average size exceeding that of the grains of the initial powder, (c) incorporating in the material the product obtained, (d) subjecting the dispersion to mechanical action to break up the granules and to release and distribute in the mass the grains of the initial powder. The invention is characterized by incorporating small particle-sized talcum powders into materials, especially thermoplastic materials, without the practical problem involved in incorporating small particle-sized powders.
Patent FI-973382-A0 (FI)
Inventor: WYTHES MARTIN JAMES
IPC: C07D403/06
Filed: 1997-08-18
Abstract: This invention relates to (R)-5-(Aminosulphonylmethyl)-3-(N-methylpyrrolidin-2-ylmethyl)-1H-indole and its pharmaceutically acceptable salts. This compound is particularly useful in treating disorders arising from deficient serotonergic neurotransmission, especially migraine.
Patent IL-84409-A0 (IL)
Title: Imidazolidinone derivatives,their preparation and pharmaceutical compositions containing them
IPC: C07D401/06
Filed: 1987-11-09
Abstract: Disclosed are imidazolidinone compounds of general formula: <CHEM> wherein R represents a substituted or unsubstituted 5- or 6-membered nitrogen-containing heterocyclic monocyclic group; the ring A represents a substituted or unsubstituted phenyl group; Y represents vinylene group or ethynylene group; m represents 1 to 6; n represents 0, 1 or 2; and Q represents methylene group or a single bond, or a salt thereof, a process for preparing the same, a pharmaceutical composition comprising the same as an active ingredient, and the use of the same for the manufacture of a medicament for the treatment of depression or peptic ulcers, as an activator of cerebral metabolism, as an agent having a nootropic effect, or for use as a brain activator.
Patent IL-86358-A0 (IL)
Title: Hebicide-resistant crop plants,process for their selection and their regeneration
IPC: C12N5/00
Filed: 1988-05-12
Abstract: Callus cultures which are able to grow on nutrient medium containing no amino acids and are able to regenerate can be used for selection on inhibitor-containing nutrient media of cell lines which can be regenerated to crop plants and are resistant to the relevant inhibitor over generations. Cell suspension cultures likewise result in inhibitor-resistant cell lines under these conditions.
Patent IL-89588-A0 (IL)
Title: 5-substituted imidazo(4,5-c)pyridines and pharmaceutical compositions containing them
IPC: A61K31/435
Filed: 1989-03-13
Abstract: This invention relates to novel substituted imidazopyridine dervatives having the following formula <CHEM>  or a pharmaceuticaly acceptable acid addition salt: wherein R1 and R2      are each independently selected from hydrogen; straight or branched chain alkyl of 1 to 15 carbon atoms; cycloalkyl having 3 to 8 carbon atoms; substituted cycloalkyl which can be substituted one or more by alkyl of 1 to 6 carbon atoms; bicycloalkyl having 3 to 8 carbon atoms in each ring; heterocyclicalkyl having 4 to 8 carbon atoms which can be optionally substituted by alkyl of 1 to 6 carbon atoms; heteroaromatic having 5 or 6 carbon atoms which can be optionally substituted by alkyl of 1 to 6 carbon atoms; phenyl; substituted phenyl which can be substituted one or more by a group independently selected from alkyl of 1 to 6 carbon atoms or halogen; straight or branched alkenyl having 3 to 15 carbon atoms with the proviso that the double bond of the alkenyl group cannot be adjacent to the nitrogen; cycloalkenyl having 5 to 8 carbon atoms with the proviso that the double bond cannot be adjacent to the nitrogen; R1 and R2 cannot both be hydrogen Y      is phenyl or phenyl substituted once or more than at one or more of the 2, 3, 5 or 6 position of the phenyl ring by substituents independently selected from the group consisting of alkoxy wherein the alkyl is 1 to 6 carbon atoms; halogen wherein the halogen is selected from bromo, fluoro, or chloro; straight or brnached chain alkyl having 1 to 6 carbon atoms; substituted straight or branched chain alkyl which can be substituted one or more by halogen; thioalkyl wherein the alkyl is 1 to 6 carbon atoms; alkoxyalkyl wherein the alkyl groups are each 1 to 6 carbon atoms; hydroxyalkyl wherein the alkyl is 1 to 6 carbon atoms; alkylthioalkyl wherein the alkyl group are each 1 to 6 carbon atoms; cyano; mercaptoalkyl wherein the alkyl is 1 to 6 carbon atoms; hydroxy; amino; alkylamino wherein the alkyl group are each 1 to 6 carbon atoms; and dialkylamino wherein the alkyl group are each 1 to 6 carbon atoms.  n      is an integer of 1 to 5. R3      is a group substituted at one or more of the 4, 6, or 7 positions of the pyridine ring said group being independently selected from hydrogen; alkyl of 1 to 6 carbon atoms; halogen wherein the halogen is selected from bromo, fluoro or chloro; alkoxy wherein the alkyl is 1 to 6 carbon atoms.  R4      is hydrogen or alkyl of 1 to 6 carbon atoms. useful in the treatment of diseases or disorders mediated by platelet-activating factor. This invention relates to pharmaceutical compositions of such substituted imidazopyridines.
Patent SE-9100015-A0 (SE)
Inventor: SÖDERSTRÖM GERT W
IPC: E03F5/042
Filed: 1991-01-03
Abstract: Floor outlet or drain that contains a housing (29) placed in the floor for the connection of outlet pipings and sewer net. Between the floor drain housing (29) and the outlet pipe a wall or lip extends up from the bottom, in order to dam up water to a water trap. In the water drain housing a floor drain insert that in its entirety is numbered (25) is lowered. An unsymmetrical funnel part (28) transcend into a cylindrical vertical tube piece (31) constituting the upper trap lip. In the piece of tubing (31) is arranged a seat (34) for a ball (33) below. The level (30) of the water trap keeps the ball (33) up towards the seat (34). The specific weight of the ball or the height of the seat above the water surface is however so chosen or adjusted, possibly by water being pumped into the ball that merely some centimeter of water column above the ball is capable of pushing this aside so that the water easily can flow down through the floor drain. Through the funnel part (28) extends sealingly a cylindricaly or tube shaped connecting part (27) that even this extends down below the water level (30). To this tubing (26) can for instance bathtub, wash basin or the like sealingly be connected. <IMAGE>
Patent AU-PN838696-A0 (AU)
Title: Genetic sequences encoding flavonoid pathway enzymes and uses therefor
IPC: A01H5/02
Filed: 1996-03-01
Abstract: The present invention relates generally to genetic sequences encoding flavonoid pathway metabolising enzymes and more particularly to flavonoid 3'-hydroxylase (hereinafter referred to as "F3'H") or derivatives thereof and their use in the manipulation of pigmentation in plants and other organisms.
Patent FI-20000887-A0 (FI)
Inventor: PALSANEN LEENA
IPC: A47C1/03
Filed: 2000-04-13
Abstract: The invention concerns a seat (10), such as an armchair or a sofa, which includes a body (11) and a bottom part (13) joined to it, which includes a cushioning (13a2). The chair includes hinge parts (16) both in the armrest parts (14a1, 14a2) and in the back part/back parts (15), whereby the said armrest parts (14a1, 14a2) an back part/back parts (15) are adapted to return in relation to the body (11) of the chair.
Patent FI-20002025-A0 (FI)
Inventor: KOISTINEN TOMMI
IPC: H04M7/00
Filed: 2000-09-14
Abstract: An arrangement of a network element, which routes communication traffic among different types of communication networks, includes a central processing unit configured to perform routing operations on the basis of a communication protocol, which forms a stack. Also, the arrangement of the network element includes devices configured to handle signal processing related issues and communicating with the central processing unit. The communication protocol stack is divided into a first stack situated in the central processing unit, which performs the routing operations of protocols in the first stack, and into a second stack, each device that handles signal processing related issues performing the operations of protocols in the second stack.
Patent IL-100462-A0 (IL)
Title: Mixed-resolution,n-dimensional object space method and apparatus
IPC: G06F13/00
Filed: 1991-12-22
Abstract: A modular, polymorphic network interconnecting a plurality of electronically reconfigurable devices via a modular, polymorphic interconnect, to permit a fixed, physical configuration of operating hardware devices to take on a plurality of logically addressable configurations. The modular, polymorphic interconnect further permits allocation and deallocation of selected electronically reconfigurable devices for a particular logically addressable configuration. The modular, polymorphic interconnect additionally permits the logical topology of selected electronically reconfigurable devices to be configured as at least one mixed-radix, N-dimensional network. The logical topology of mixed-radix, N-dimensional networks can be dynamically changed under control for a new configuration of logical addresses for selected electronically reconfigurable devices. The modular, polymorphic interconnect also permits one or more electronically reconfigurable devices to be selected from at least one logically related set of electronically reconfigurable devices, making the resulting network system particularly well suited for a variety of purposes related to resource management.
Patent IL-105203-A0 (IL)
Title: Sweetened extruded food product and a process for the manufacture thereof
IPC: A23J3/26
Filed: 1993-03-29
Abstract: A sweetened extruded food product based on a vegetable material containing sweetener incorporated before extrusion, is formulated so that the sweetener comprises a significant proportion of sucralose. In particular, the sucralose provides at least 50%, preferably at least 75% of the sweetness.
Patent IL-106527-A0 (IL)
Title: Novel sulfonylureas
IPC: A01P21/00
Filed: 1993-07-29
Abstract: N-Pyridylsulphonyl-N'-pyrimidinylureas of the formula I <IMAGE>  in which     R1 represents methyl or methoxy and   R2 represents hydrogen or methyl; and the salts of these compounds with amines, alkali metal bases or alkaline earth metal bases or with quaternary ammonium bases have good selective herbicidal and growth-regulating properties when used pre- and post-emergence.
Patent IL-125824-A0 (IL)
Title: Dispersions of delaminated particles in polymer foams
IPC: C08J9/04
Filed: 1997-02-20
Abstract: This invention relates to a polymer foam prepared by dispersing an organophilic multi-layered material into a melt comprising an olefinic or styrenic polymer having polar functionality so that at least a portion of the polymer intercalates between layers of the particles; and expanding the polymer with a blowing agent under such condition to form the polymer foam. The organophilic multi-layered material can also be dispersed into an olefinic or styrenic monomer, which can then be polymerized to form a polymer melt prior to, or along with the foaming step.
Patent IL-127809-A0 (IL)
Title: Self-tapping screw in particular concerete screw
IPC: F16B25/02
Filed: 1997-07-18
Abstract: PCT No. PCT/EP97/03867 Sec. 371 Date Jan. 25, 1999 Sec. 102(e) Date Jan. 25, 1999 PCT Filed Jul. 18, 1997 PCT Pub. No. WO98/04842 PCT Pub. Date Feb. 5, 1998A self-tapping screw, in particular a concrete screw, comprises a cylindrical core with a central longitudinal axis and a thread designed in a single piece with the core and provided, in the area of its periphery, with cutting notches formed by triangles open towards the periphery of the thread. The flanks of the thread extend substantially in parallel to each other radially to the central longitudinal axis.
Patent IL-131882-A0 (IL)
Title: An improved process for the conversin of 2-(methylthio)-5-(trifluoromethyl) - 1, 3, 4-thiadiazole (tda) to 2-(methylsulfonyl) -5- (trifluoromethyl) -1, 3, 4-thiadiazole (tda-sulfone)
IPC: C07D285/12
Filed: 1999-09-14
Abstract: The present invention provides a process for making thiadiazole sulfones. In particular, the present process is used to make 2-(methylsulfonyl)-5-(trifluoromethyl)-1,3,4-thiadiazole using catalytic oxidation in the presence of a suitable oxidizing agent. The catalyst system used for the oxidation reaction is a mixture of glacial acetic acid and a tungsten catalyst. The tungsten catalyst is preferably selected from the group consisting of sodium tungstate, potassium tunstate, and tungstic acid.
Patent IL-140650-A0 (IL)
Title: Delivery system
IPC: A61K47/42
Filed: 1999-06-22
Abstract: The present invention relates to a novel drug delivery system of use in the improved delivery of drug therapeutic agents into target cells. The system comprises a drug moiety linked to a carrier moiety wherein the carrier moiety comprises a homeobox peptide or a fragment or derivative thereof.
Patent IL-145612-A0 (IL)
Title: Denture adhesive compositions
IPC: A61L24/00
Filed: 2000-04-13
Abstract: The present invention relates to a denture adhesive composition comprising mixed salts of an alkyl vinyl ether-maleic acid or anhydride copolymer and/or terpolymer with isobutylene wherein the mixed salt contains a cationic salt function comprising at least about 22.5 % calcium cations, from about 15 % to about 25 % of zinc cations, of the total initial carboxyl groups reacted, the mixed salt containing from about 36 % to about 50 % free acid component. In addition the present invention relates to denture adhesive compositions comprising the above composition and at least one non-adhesive self-supporting layer. The present invention further relates to a method of increasing the adhesion of dentures to the oral cavity by applying the above compositions to dentures, directly to the oral cavity, palate or ridge of the oral cavity, or applying it to both, and thereafter securing the denture to the ridge or palate of the oral cavity.
Patent IL-150704-A0 (IL)
Title: Mine protective floor of an armored vehicle
IPC: F41H7/04
Filed: 2002-07-11
Abstract: Device for protecting against the effect of a landmine, especially for fitting to an armored vehicle by attaching the protective elements to the vehicle base, comprises a concave homogeneous base protection plate (1) having a large radius (7) whose center of the circle lies below the plate. Preferred Features: Elements above the base protection plate in the sump, e.g. torsion bars (2), are positioned a free distance (14) away from the base plate so that they remain undamaged on detonation of a mine and formation of a dynamic dent in the base plate. The base protection plate has a multilayered construction and/or is designed as a sandwich plate.